Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Bristol-Myers Squibb Company    BMY

BRISTOL-MYERS SQUIBB COMPANY

(BMY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about BRISTOL-MYERS SQUIBB COMPA
05/29BRISTOL MYERS SQUIBB : to Hold Virtual Three-Part Investor Series
BU
05/28BRISTOL MYERS SQUIBB : Receives European Commission Approval for Zeposia for the..
AQ
05/28TCR-2 Therapeutics Hires Key Business Development and Regulatory Affairs Cell..
AQ
05/27BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Opdivo + Yervo..
AQ
05/27BRISTOL MYERS SQUIBB : Gets European Union Approval for MS Drug Zeposia
DJ
05/27BRISTOL MYERS SQUIBB : Receives European Commission Approval for Zeposia (ozanim..
BU
05/26BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Opdivo® (nivol..
BU
05/25BRISTOL MYERS SQUIBB : European Medicines Agency Validates Bristol Myers Squibb'..
AQ
05/22Bristol Myers Says EMA Validates Applications for Idecabtagene Vicleucel, CC-..
DJ
05/22BRISTOL MYERS SQUIBB : European Medicines Agency Validates Bristol Myers Squibb'..
BU
05/21ACCELERON PHARMA : Announces Presentations on REBLOZYL at the 2020 American Soci..
AQ
05/20BRISTOL MYERS SQUIBB : Research at EHA 2020 Demonstrates Continued Advances Acro..
BU
05/18BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Opdivo + Yervo..
AQ
05/18BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Bristol Myers ..
AQ
05/15BRISTOL MYERS SQUIBB : FDA Approves Another Indication for Combination of Opdivo..
DJ
05/15BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Opdivo® (nivol..
BU
05/15BRISTOL MYERS SQUIBB : Myers Gets FDA OK of Pomalyst for AIDS-Related, HIV-Negat..
DJ
05/15BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Bristol Myers ..
BU
05/14BRISTOL MYERS SQUIBB : Opdivo Plus Yervoy with Limited Chemotherapy Significantl..
AQ
05/14BRISTOL MYERS SQUIBB : and bluebird bio Provide Regulatory Update on Idecabtagen..
AQ
05/14BRISTOL MYERS SQUIBB : Three-Year Data from CheckMate -227 Confirm Durable, Long..
AQ
05/13BRISTOL MYERS SQUIBB AND BLUEBIRD BI : to Present Updated Positive Results from ..
BU
05/13BRISTOL MYERS SQUIBB : Opdivo (nivolumab) Plus Yervoy (ipilimumab) with Limited ..
BU
05/13BRISTOL MYERS SQUIBB : Three-Year Data from CheckMate -227 Confirm Durable, Long..
BU
05/13BRISTOL MYERS SQUIBB : FDA Turns Away Bristol-Myers, Bluebird Ide-Cel Applicatio..
DJ
05/13BRISTOL MYERS SQUIBB : and bluebird bio Provide Regulatory Update on Idecabtagen..
BU
05/12BRISTOL MYERS SQUIBB : to Take Part in the UBS Virtual Global Healthcare Confere..
BU
05/12BRISTOL MYERS SQUIBB : GRYT Health and Bristol Myers Squibb Team Up to Launch CO..
BU
05/11Bluebird Bio Amends Promotion/Development Agreement With Bristol Myers
DJ
05/11BRISTOL MYERS SQUIBB : Research at ASCO Demonstrates Diverse Approaches in Treat..
BU
05/07Travel Sites Take a Hit from the Pandemic -- -2-
DJ
05/07Travel Sites Take a Hit from the Pandemic -- Earnings at a Glance
DJ
05/07BRISTOL MYERS SQUIBB : 2019-2020 Product Sales Summary
PU
05/07GLOBAL MARKETS LIVE: Merger between 02 and Virgin goes ahead
05/07BRISTOL MYERS SQUIBB : Myers Assuming Covid-19 Effects Peak In 2Q
DJ
05/07BRISTOL MYERS SQUIBB : Myers 1Q Revenue Helped by Covid-19
DJ
05/07BRISTOL-MYERS : 1Q Earnings Snapshot
AQ
05/07BRISTOL MYERS SQUIBB : Reports Strong First Quarter 2020 Financial Results
BU
05/06BRISTOL-MYERS : FDA Extends Liso-Cel Action Date by Three Months
DJ
05/06BRISTOL MYERS SQUIBB : Provides Update on Biologics License Application (BLA) fo..
BU
05/04BRISTOL MYERS SQUIBB : Ayala Sets IPO at 3.33 Million Shares; Sees Pricing at $1..
DJ
05/04BRISTOL-MYERS SQUIBB COMPANY : quaterly earnings release
05/04BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Accepts for Priority Re..
AQ
05/01BRISTOL MYERS SQUIBB : FDA Accepts Bristol Myers CC-486 NDA for Priority Review
DJ
05/01BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration (FDA) Accepts for Prior..
BU
05/01BRISTOL MYERS SQUIBB : Reblozyl Receives Positive CHMP Opinion for the Treatment..
AQ
04/30BRISTOL MYERS SQUIBB : Acceleron Pharma's Anemia Treatment Gets Nod From Europea..
DJ
04/30BRISTOL MYERS SQUIBB : Reblozyl (luspatercept) Receives Positive CHMP Opinion fo..
BU
04/27BRISTOL MYERS SQUIBB : Defendant Seeks Rehearing En Banc On Seventh Circuit's De..
AQ
04/21Bristol Myers Squibb and Exelixis Announce Positive Topline Results from Pivo..
AQ
04/21Ono and Takeda Announce Results from Phase 3 CheckMate -9ER Study for Opdivo ..
AQ
04/21BRISTOL MYERS SQUIBB : Announces Positive Topline Result from Pivotal Phase 3 Tr..
AQ
04/20United Airlines, Lennox fall; Bristol-Myers, M&T Bank rise
AQ
04/20EXELIXIS : Shares Hit 52-Week High on Phase 3 Study Data
DJ
04/20BRISTOL-MYERS : Opdivo/Yervoy Meets Main Endpoint in Treating Rare Lung Cancer
DJ
04/20BRISTOL MYERS SQUIBB : Myers, Exelixis Phase 3 Kidney Cancer Study Meets Main En..
DJ
04/20BRISTOL MYERS SQUIBB : Announces Positive Topline Result from Pivotal Phase 3 Tr..
BU
04/20BRISTOL MYERS SQUIBB : and Exelixis Announce Positive Topline Results from Pivot..
BU
04/14BRISTOL MYERS SQUIBB : Announces Virtual 2020 Annual Meeting of Shareholders
BU
04/09BRISTOL MYERS SQUIBB : Announces Acceptance of U.S. and EU Regulatory Filings fo..
AQ
04/08BRISTOL MYERS SQUIBB : Myers Gets FDA Priority Review for Opdivo/Yervoy Plus Che..
DJ
04/08BRISTOL MYERS SQUIBB : Announces Acceptance of U.S. and EU Regulatory Filings fo..
BU
04/07UPDATED STATEMENT : Bristol Myers Squibb on Coronavirus (COVID-19)
PU
04/07BRISTOL MYERS SQUIBB : Expands Patient Support Programs to Help Newly Uninsured ..
BU
04/06ACCELERON PHARMA : Bristol-Myers Shares Up After New FDA Nod for Reblozyl
DJ
04/06BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Reblozyl, the ..
AQ
04/03BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration (FDA) Approves Reblozyl..
BU
04/02BRISTOL-MYERS SQUIBB COMPANY : Ex-dividend day for
FA
04/01BRISTOL MYERS SQUIBB : and bluebird bio Announce Submission of Biologics License..
AQ
03/31Bristol Myers, Bluebird Submit Biologics License Application for Idecabtagene..
DJ
03/31BRISTOL MYERS SQUIBB : and bluebird bio Announce Submission of Biologics License..
BU
03/31CYTOMX THERAPEUTICS : Announces Milestone Achievement in AbbVie CD71 Partnership..
AQ
03/30BRISTOL MYERS SQUIBB : Receives Positive CHMP Opinion Recommending Approval of Z..
AQ
03/27BRISTOL MYERS SQUIBB : Myers Gets Positive CHMP Opinion for Zeposia
DJ
03/27BRISTOL MYERS SQUIBB : Receives Positive CHMP Opinion Recommending Approval of Z..
BU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on BRISTOL-MYERS SQUIBB COMPA